Explore ›
Finding
Finding
decline
Higher baseline sE-selectin was the most robust biomarker predictor of incident diabetes in the placebo group, remaining significant after adjustment for traditional diabetes risk factors, 1-year changes in risk factors, and all other biomarkers.
| Effect size | HR 1.19 |
| CI | 95% CI 1.06, 1.34 |
| Follow-up | 1 year |
| Comparator | per 1 SD increase in baseline sE-selectin (placebo/standard care group) |
| Effect summary | decline; HR 1.19; CI: 95% CI 1.06, 1.34 |
Connected entities
Interventions
Conditions
Outcomes
Source
PMC6456055
Non-traditional biomarkers and incident diabetes in the Diabetes Prevention Program: comparative effects of lifestyle and metformin interventions